Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bioqube Ventures is a global life sciences investment firm founded in 2015, with offices located in Brussels, Belgium, and San Diego, California, USA. The firm focuses on investing in companies that develop first- or best-in-class therapeutics aimed at addressing significant unmet medical needs. Bioqube Ventures employs a stage-agnostic investment approach, supporting companies from inception through early clinical milestones.
Since its inception, Bioqube Ventures has backed over 20 biotech companies, demonstrating a commitment to fostering innovation in the life sciences sector. The firm has a total fund size of $66 million and a portfolio that includes 10 active companies. Their investment strategy emphasizes strong biological rationale and disciplined execution, ensuring that they back innovative solutions in the biotech and healthcare sectors across Europe and North America.
Bioqube Ventures invests in therapeutics targeting severe or life-threatening diseases, with a commitment to improving both the length and quality of life for patients. Their investment strategy includes venture creation, early-stage company building, and selective clinical co-investment. This dual strategy allows Bioqube to actively participate in the development of its portfolio companies, ensuring that they are well-positioned to succeed in the competitive biotech landscape.
The firm primarily focuses on the life sciences sector, particularly in biotech and healthcare. Their stage-agnostic approach enables them to support companies at various stages, from pre-seed to Series C. Bioqube Ventures seeks to invest in companies that demonstrate a strong biological rationale and have the potential to develop first- or best-in-class therapeutics. They prioritize partnerships with innovative startups that align with their mission of transforming scientific discoveries into effective medicines.
Bioqube Ventures has a diverse portfolio of companies in the biotech sector, with notable investments including:
These companies represent Bioqube's commitment to supporting innovative solutions in the life sciences sector, particularly in the development of therapeutics that address critical medical needs.
Debora Dumont: Co-founder and Managing Partner. Debora has extensive experience in the biotech sector and has been instrumental in shaping Bioqube's investment strategy.
Nico Vandervelpen: Co-founder and Managing Partner. Nico brings a wealth of knowledge in venture capital and life sciences, contributing to the firm's growth and portfolio development.
Dirk Reyn: Managing Partner BFF I. Dirk has a strong background in biotech investments and plays a key role in portfolio management.
Tessa Ceyssens: Chief Operating Officer (COO). Tessa oversees the firm's operations and has a background in managing biotech companies.
Joris Vanderlocht: Partner and Chief Scientific Officer (CSO). Joris provides scientific expertise and guidance to portfolio companies, ensuring alignment with Bioqube's investment thesis.
Geert Tackaert: Finance Director. Geert manages the financial operations of the firm, ensuring sound fiscal management.
Janine Schuurman: Senior Advisor. Janine offers strategic insights and guidance based on her extensive experience in the biotech industry.
Alexander Demoulin: Principal. Alexander focuses on sourcing and evaluating new investment opportunities.
Clément Salque: Senior Associate. Clément supports the investment team in due diligence and portfolio management.
Joris De Maeyer: Entrepreneur In Residence. Joris provides mentorship and guidance to portfolio companies.
Roderick Verhelst: Partner. Roderick plays a key role in investment decisions and portfolio strategy.
Sandy Zweifach: Senior Advisor. Sandy offers insights based on her extensive experience in the life sciences sector.
Sylvie Schrijvers: Senior Executive Assistant & Office Manager. Sylvie manages the firm's administrative operations.
To pitch to Bioqube Ventures, founders should use the contact form available on their website. It is important to include a comprehensive deck that outlines the business model, technology, and team qualifications. Bioqube Ventures prefers detailed information about the scientific rationale and potential market impact of the proposed therapeutics.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
Bioqube Ventures has launched the Bioqube Factory Fund I and Bioqube Factory Fund II, which are supported by InnovFin Equity and the European Union under Horizon 2020 Financial Instruments and the InvestEU Fund. These funds aim to support financing and implementing productive investments in the life sciences sector.
The Bioqube Factory Funds focus on early-stage biotech companies, providing them with the necessary capital and resources to develop innovative therapeutics that address critical medical needs.
In recent months, Bioqube Ventures has made significant strides in strengthening its leadership team. Tessa Ceyssens has been appointed as Chief Operating Officer, bringing valuable operational expertise to the firm.
Additionally, Bioqube Ventures announced the successful close of Series B financing for Primmune Therapeutics, a notable portfolio company engaged in clinical studies for melanoma. This funding will support the company's ongoing clinical trials and development efforts.
The firm has also published blog posts highlighting developments within its portfolio, including the establishment of a clinical study advisory board for Primmune Therapeutics, which aims to enhance the company's clinical strategy and execution.
What are Bioqube Ventures' investment criteria?
Bioqube Ventures invests in companies developing first- or best-in-class therapeutics, primarily in the biotech and healthcare sectors. They focus on companies that target severe or life-threatening diseases and demonstrate a strong biological rationale.
How can I apply or pitch to Bioqube Ventures?
Founders can pitch their ideas through the contact form available on the Bioqube Ventures website. It is recommended to include a detailed business plan and information about the team and technology.
What makes Bioqube Ventures different from other investors?
Bioqube Ventures employs a stage-agnostic investment approach, actively creating and incubating biotech startups rather than solely providing capital. Their unique company-building model allows them to offer operational support and access to industry networks.
What is the geographic scope of Bioqube Ventures?
Bioqube Ventures has a global investment focus, with particular emphasis on North America and Europe. They seek to support innovative biotech companies in these regions.
What is the typical check size for investments?
While specific check sizes are not disclosed, Bioqube Ventures invests across various stages, including pre-seed, seed, and Series A to C, indicating a flexible approach to funding.
What kind of post-investment involvement does Bioqube Ventures have?
Bioqube Ventures provides operational support and strategic partnerships to its portfolio companies, helping them navigate the complexities of the biotech industry and achieve their clinical milestones.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.